This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Melatonin

Melatonin is a pineal and tissue-derived circadian hormone best known for sleep timing. In cancer discussions it is studied for circadian biology, antioxidant and mitochondrial effects, immune signaling, possible treatment-toxicity reduction, and light-at-night disruption. It is not a stand-alone cancer treatment. Connection to Cancer Melatonin is a hormone and signaling molecule produced by the pineal gland at night.

Doctors

Dr. Casey Peavler

doctor

Public educator whose alternative-platform material discusses berberine in cancer-metabolism contexts. Dr. Casey Peavler is a person tracked in this database because they are connected to cancer-related books, media, protocols, organizations, clinical care, advocacy, research, education, products, or patient support. Review linked records and source notes for role, credentials, perspective, claims, and relevance before relying on the information.

Dr. Frank Shallenberger

doctor

Integrative physician and speaker discussing high-dose melatonin as an adjunctive anticancer therapy. Dr. Frank Shallenberger is a person tracked in this database because they are connected to cancer-related books, media, protocols, organizations, clinical care, advocacy, research, education, products, or patient support. Review linked records and source notes for role, credentials, perspective, claims, and relevance before relying on the information.

Dr. Hugo Castro

doctor, oncologist

Oncologist who has discussed melatonin in cancer treatment in Spanish-language patient education media. Dr. Hugo Castro is a person tracked in this database because they are connected to cancer-related books, media, protocols, organizations, clinical care, advocacy, research, education, products, or patient support. Review linked records and source notes for role, credentials, perspective, claims, and relevance before relying on the information.

Paolo Lissoni

doctor

Oncology researcher associated with early clinical trials of melatonin in advanced cancer and treatment-toxicity reduction. Paolo Lissoni is a person tracked in this database because they are connected to cancer-related books, media, protocols, organizations, clinical care, advocacy, research, education, products, or patient support. Review linked records and source notes for role, credentials, perspective, claims.
All Protocols